Greyhound Meet & Greet

NJ Greyhound Adoption Program will host a Meet & Greet at PetValu at the Flemington Circle Shopping Center on Saturday, Dec. 9 from 1- to 4 p.m. NJGAP volunteers and their dogs will be there to discuss greyhound adoption with the public. NJGAP recently received three ex-racing greyhounds on Dec. 2.  "Lee," a male red fawn greyhound from that shipment will be at PetValu for the public to meet.

Contact Information
  1. NJ Greyhound Adoption Program
  2. 908-713-9344
  3. njgap@hotmail.com
Sat, December 09
1:00 pm — 4:00 pm
Add to My Calendar 12/09/2017 1:00pm 12/09/2017 4:00pm America/New_York Greyhound Meet & Greet

NJ Greyhound Adoption Program will host a Meet & Greet at PetValu at the Flemington Circle Shopping Center on Saturday, Dec. 9 from 1- to 4 p.m. NJGAP volunteers and their dogs will be there to discuss greyhound adoption with the public. NJGAP recently received three ex-racing greyhounds on Dec. 2. "Lee," a male red fawn greyhound from that shipment will be at PetValu for the ...

276 Rt. 202-31 Flemington, NJ 08822 [40.4989596, -74.8560431]

PetValu

276 Rt. 202-31
Flemington, NJ 08822

Sign Up for E-Calendar

Flemington/Raritan
FILED UNDER

Giving Back

TAP Into Another Town's News:

TAP Into Another Town's News:

Sign Up for E-Calendar

Flemington/Raritan

AtlantiCast

AtlantiCast: Episode 010

On this week’s AtlantiCast, we take you to the groundbreaking for an expansion to Morristown Medical Center, introduce you to the newest babies of 2018 at Atlantic Health System and share some must-see winter weather tips!

 

'Affordable' Housing Deal Signed Without Public Input

January 16, 2018

To the editor:

Across New Jersey the Fair Share Housing Center – a group of lawyers who make their money building and renting affordable housing – is threatening and suing towns in a blatant attempt to control local zoning. While all towns must fulfill an obligation to provide affordable housing, FSHC has now become the arbiter of “how much” and is ...

Brain Cancer Study Opens at Overlook Medical Center

January 16, 2018

Kurt Jaeckle, MD, co-director of the Gerald J. Glasser Brain Tumor Center at Overlook Medical Center, and medical director of the Atlantic Center for Research, is leading a phase III study of novel drug VAL-083, which has already shown promise in Glioblastoma and other cancers. The study is for patients whose glioblastoma multiforme or gliosarcoma has progressed during or after treatment with the ...